The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Neoadjuvant Chemotherapy for Patients With High-Grade Endometrial Cancer

Alon Altman, MD
Published Online: 6:30 PM, Tue March 14, 2017

Alon Altman, MD, associate professor, Department of Obstertrics, Gynecology and Reproductive Sciences, University of Manitoba, discusses neoadjuvant chemotherapy for patients with high-grade serous carcinoma. Across the world, many centers have shifted to more patients receiving neoadjuvant chemotherapy followed by surgery and further chemotherapy.



Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.